Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Merrill

Showing results (211-220 of 414) with videos related to

Pageof 42
Sort By:
Lupus Science & Medicine|December 8, 2017
Identification of biomarkers of response to abatacept in patients with SLE using deconvolution of whole blood transcriptomic data from a phase IIb clinical trialSomnath Bandyopadhyay, Sean E Connolly, Omar Jabado, et al.
Rheumatology (Oxford, England)|February 29, 2020
Attainment of treat-to-target endpoints in SLE patients with high disease activity in the atacicept phase 2b ADDRESS II studyEric F Morand, David A Isenberg, Daniel J Wallace, et al.
Journal of Autoimmunity|April 30, 2013
Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naïve CD4+ T cells from lupus patientsPatrick Coit, Matlock Jeffries, Nezam Altorok, et al.
Frontiers in Immunology|June 14, 2021
Immune Response to <i>Enterococcus gallinarum</i> in Lupus Patients Is Associated With a Subset of Lupus-Associated AutoantibodiesHarini Bagavant, Antonina M Araszkiewicz, Jessica K Ingram, et al.
RMD Open|August 19, 2025
Efficacy and safety of upadacitinib as monotherapy or combined with elsubrutinib for the treatment of systemic lupus erythematosus: results through 104 weeks in a long-term extension studyJoan T Merrill, Amit Saxena, Martin Aringer, et al.
Annals of the Rheumatic Diseases|June 16, 2022
Hypomethylation of miR-17-92 cluster in lupus T cells and no significant role for genetic factors in the lupus-associated DNA methylation signaturePatrick Coit, Xiavan Roopnarinesingh, Lourdes Ortiz-Fernández, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Inhibition of methotrexate-induced rheumatoid nodulosis by colchicine: evidence from an in vitro model and regression in 7 of 14 patientsJ T Merrill, C Diakolios, S Goodman, et al.
Mededportal : the Journal of Teaching and Learning Resources|March 31, 2023
Teaching the Teachers: Development and Evaluation of a Racial Health Equity Curriculum for FacultyOlanrewaju Falusi, Lin Chun-Seeley, Desiree de la Torre, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 8, 2018
Brief Report: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus ArthritisLaurence E Cheng, Zahir Amoura, Benjamin Cheah, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|April 21, 2016
Forming a Consensus: Data and Guidance for Physicians Treating Diabetic Macular EdemaCarmen A Puliafito, Scott W Cousins, Jason Bacharach, et al.
Pageof 42

Showing results (211-220 of 414) with videos related to

Sort By:
Pageof 42
Lupus Science & Medicine|December 8, 2017
Identification of biomarkers of response to abatacept in patients with SLE using deconvolution of whole blood transcriptomic data from a phase IIb clinical trialSomnath Bandyopadhyay, Sean E Connolly, Omar Jabado, et al.
Rheumatology (Oxford, England)|February 29, 2020
Attainment of treat-to-target endpoints in SLE patients with high disease activity in the atacicept phase 2b ADDRESS II studyEric F Morand, David A Isenberg, Daniel J Wallace, et al.
Journal of Autoimmunity|April 30, 2013
Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naïve CD4+ T cells from lupus patientsPatrick Coit, Matlock Jeffries, Nezam Altorok, et al.
Frontiers in Immunology|June 14, 2021
Immune Response to <i>Enterococcus gallinarum</i> in Lupus Patients Is Associated With a Subset of Lupus-Associated AutoantibodiesHarini Bagavant, Antonina M Araszkiewicz, Jessica K Ingram, et al.
RMD Open|August 19, 2025
Efficacy and safety of upadacitinib as monotherapy or combined with elsubrutinib for the treatment of systemic lupus erythematosus: results through 104 weeks in a long-term extension studyJoan T Merrill, Amit Saxena, Martin Aringer, et al.
Annals of the Rheumatic Diseases|June 16, 2022
Hypomethylation of miR-17-92 cluster in lupus T cells and no significant role for genetic factors in the lupus-associated DNA methylation signaturePatrick Coit, Xiavan Roopnarinesingh, Lourdes Ortiz-Fernández, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Inhibition of methotrexate-induced rheumatoid nodulosis by colchicine: evidence from an in vitro model and regression in 7 of 14 patientsJ T Merrill, C Diakolios, S Goodman, et al.
Mededportal : the Journal of Teaching and Learning Resources|March 31, 2023
Teaching the Teachers: Development and Evaluation of a Racial Health Equity Curriculum for FacultyOlanrewaju Falusi, Lin Chun-Seeley, Desiree de la Torre, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 8, 2018
Brief Report: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus ArthritisLaurence E Cheng, Zahir Amoura, Benjamin Cheah, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|April 21, 2016
Forming a Consensus: Data and Guidance for Physicians Treating Diabetic Macular EdemaCarmen A Puliafito, Scott W Cousins, Jason Bacharach, et al.
Pageof 42